Zdrowie i gospodarka · 18/12/2024

FDA Announces FY 2025 Generic Drug Science and Research Initiatives Workshop for Public Input

The US Food and Drug Administration (FDA) is hosting a public workshop to gather input on its annual list of science and research initiatives for generic drugs, as mandated by the Generic Drug User Fee Amendments of 2022 (GDUFA III). The workshop aims to provide an overview of current initiatives and allow the public to share their thoughts on future projects.